Itonis, Inc. Announces Selection of New Manufacturer for Emesyl Anti-Nausea Relief

LAGUNA HILLS, CA / ACCESSWIRE / March 28, 2016 / Itonis, Inc. (OTC PINKSHEETS: ITNS) Itonis, Inc. is pleased to announce that National Homeopathic Labs will be the new manufacturer for its anti-nausea product, Emesyl. National Homeopathic Labs is a cGMP, FDA registered contract manufacturer that has specialized in formula development and packaging of homeopathic, nutritional, cosmeceutical, and dietary supplements for over 25 years.

Itonis has placed its first purchase order with National Homeopathic Labs and is expecting delivery of its first batch of product within the next 2 months.

“We are very pleased to be working with National Homeopathic Labs and look forward to a long standing relationship with them,” said Steve Pidliskey, Itonis Vice President. “Once they delivered the first batch of samples to us and we had time to test them, we immediately knew we had a sure winner.”

About Itonis, Inc.

Located in Laguna Hills, California, and founded in 2005, Itonis Inc. has focused on the distribution of innovative products to the medical and pharmaceutical industries. The company also holds a licensing agreement with MyECheck Inc, which allows the company to use MyEChecks patented mobile payment application and share transaction revenue fees for point of purchase payments across various industries. Please visit www.itonisholdings.com for additional information.

About National Homeopathic Labs

Located in Las Vegas, Nevada, the company is a cGMP, FDA registered contract manufacturer that specializes in formula development and packaging of homeopathic, nutritional, cosmeceutical, and dietary supplements.

Safe Harbor:

Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company’s future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company’s affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company’s filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.

Contact:

Itonis, Inc.
Office@itonisholdings.com

SOURCE: Itonis, Inc.

ReleaseID: 438195